Literature DB >> 8898341

Geographical distribution of a variant epitope of Pfs48/45, a Plasmodium falciparum transmission-blocking vaccine candidate.

C J Drakeley1, M T Duraisingh, M Póvoa, D J Conway, G A Targett, D A Baker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8898341     DOI： 10.1016/0166-6851(96)02718-1

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  9 in total

1.  Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe.

Authors:  Noah H Paul; Arthur Vengesai; Takafira Mduluza; James Chipeta; Nicholas Midzi; Geetha P Bansal; Nirbhay Kumar
Journal:  Acta Trop       Date:  2016-08-01       Impact factor: 3.112

Review 2.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Synthesis and antimalarial activity of amide and ester conjugates of siderophores and ozonides.

Authors:  Rohit Tiwari; Lisa Checkley; Michael T Ferdig; Jonathan L Vennerstrom; Marvin J Miller
Journal:  Biometals       Date:  2022-03-01       Impact factor: 3.378

4.  Rare Alleles and Signatures of Selection on the Immunodominant Domains of Pfs230 and Pfs48/45 in Malaria Parasites From Western Kenya.

Authors:  Kevin O Ochwedo; Fredrick O Ariri; Wilfred O Otambo; Edwin O Magomere; Isaiah Debrah; Shirley A Onyango; Pauline W Orondo; Harrysone E Atieli; Sidney O Ogolla; Antony C A Otieno; Wolfgang R Mukabana; Andrew K Githeko; Ming-Chieh Lee; Guiyun Yan; Daibin Zhong; James W Kazura
Journal:  Front Genet       Date:  2022-05-17       Impact factor: 4.772

Review 5.  Malaria gametocytogenesis.

Authors:  David A Baker
Journal:  Mol Biochem Parasitol       Date:  2010-04-08       Impact factor: 1.759

6.  Population genetic analysis of large sequence polymorphisms in Plasmodium falciparum blood-stage antigens.

Authors:  Ambroise D Ahouidi; Amy K Bei; Daniel E Neafsey; Ousmane Sarr; Sarah Volkman; Dan Milner; Janet Cox-Singh; Marcelo U Ferreira; Omar Ndir; Zul Premji; Souleymane Mboup; Manoj T Duraisingh
Journal:  Infect Genet Evol       Date:  2009-11-30       Impact factor: 3.342

7.  Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential.

Authors:  Kara A Moser; Elliott F Drábek; Ankit Dwivedi; Emily M Stucke; Jonathan Crabtree; Antoine Dara; Zalak Shah; Matthew Adams; Tao Li; Priscila T Rodrigues; Sergey Koren; Adam M Phillippy; James B Munro; Amed Ouattara; Benjamin C Sparklin; Julie C Dunning Hotopp; Kirsten E Lyke; Lisa Sadzewicz; Luke J Tallon; Michele D Spring; Krisada Jongsakul; Chanthap Lon; David L Saunders; Marcelo U Ferreira; Myaing M Nyunt; Miriam K Laufer; Mark A Travassos; Robert W Sauerwein; Shannon Takala-Harrison; Claire M Fraser; B Kim Lee Sim; Stephen L Hoffman; Christopher V Plowe; Joana C Silva
Journal:  Genome Med       Date:  2020-01-08       Impact factor: 11.117

8.  Genetic polymorphism of Merozoite Surface Protein 1 (msp1) and 2 (msp2) genes and multiplicity of Plasmodium falciparum infection across various endemic areas in Senegal.

Authors:  Tolla Ndiaye; Mouhamad Sy; Amy Gaye; Daouda Ndiaye
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

9.  NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.

Authors:  Anne C Teirlinck; Meta Roestenberg; Marga van de Vegte-Bolmer; Anja Scholzen; Moniek J L Heinrichs; Rianne Siebelink-Stoter; Wouter Graumans; Geert-Jan van Gemert; Karina Teelen; Martijn W Vos; Krystelle Nganou-Makamdop; Steffen Borrmann; Yolanda P A Rozier; Marianne A A Erkens; Adrian J F Luty; Cornelus C Hermsen; B Kim Lee Sim; Lisette van Lieshout; Stephen L Hoffman; Leo G Visser; Robert W Sauerwein
Journal:  J Infect Dis       Date:  2012-11-27       Impact factor: 5.226
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.